Skip to main content

VanEck Vectors Biotech ETF (BBH)

NASDAQ: BBH · IEX Real-Time Price · USD
208.45 -6.16 (-2.87%)
Sep 27, 2021 4:00 PM EDT - Market closed
Assets$627.45M
NAV$218.51
Expense Ratio0.35%
PE Ratio31.66
Shares Out2.87M
Dividend (ttm)$0.61
Dividend Yield0.28%
Ex-Dividend DateDec 21, 2020
1-Year Return
-
Volume29,846
Open214.19
Previous Close214.61
Day's Range207.93 - 214.19
52-Week Low150.00
52-Week High222.22
Beta0.90
Holdings26
Inception DateDec 20, 2011

About BBH

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Asset ClassEquity
SectorBiotech
RegionNorth America
IssuerVan Eck Associates
Stock ExchangeNASDAQ
Ticker SymbolBBH
Index TrackedMVIS US Listed Biotech 25 Index

Top 10 Holdings

58.69% of assets
NameSymbolWeight
ModernaMRNA12.07%
AmgenAMGN7.78%
Gilead SciencesGILD5.33%
IQVIA HoldingsIQV5.05%
ICON plcICLR4.96%
Vertex PharmaceuticalsVRTX4.85%
Regeneron PharmaceuticalsREGN4.83%
IlluminaILMN4.73%
BiogenBIIB4.59%
BioNTech SEBNTX4.51%
View More Holdings

Dividends

Ex-DividendAmountPay Date
Dec 21, 2020$0.6079Dec 28, 2020
Dec 23, 2019$0.4724Dec 30, 2019
Dec 20, 2018$0.551Dec 27, 2018
Dec 18, 2017$0.683Dec 22, 2017
Dec 19, 2016$0.327Dec 23, 2016
Dec 21, 2015$0.337Dec 28, 2015
Full Dividend History

News

Biotech Stocks Have Colds, but They Can Heal

This year hasn't been kind to biotechnology stocks and related exchange traded funds. The headwinds faced by these assets were ratcheted up last week when the Biden administration revealed plans to purs...

Other symbols:SBIOBBCIBB
2 weeks ago - ETF Trends

Best ETF Areas for Placing Your Bets in September

Let's take a look at some ETF areas that can be good investment options for September.

3 weeks ago - Zacks Investment Research

5 Top-Ranked ETFs That Outperformed in August

Let's take a look at some top-ranked ETFs that outperformed Wall Street in August.

Other symbols:FTXOIYWPFERPGXSD
3 weeks ago - Zacks Investment Research

Biotech ETFs to Benefit From Latest Booster Update

The U.S. government's plans to make COVID-19 vaccine booster shots available from next month will likely increase the profits of vaccine makers.

1 month ago - Zacks Investment Research

How Are Biotech ETFs Reacting to These Q2 Earnings Releases?

Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.

Other symbols:AMGNBIIBGILDIBBXBI
1 month ago - Zacks Investment Research

ETF Investing Areas to Consider for August

Let's take a look at some ETF areas that can be good investment options for August.

1 month ago - Zacks Investment Research

Delta Variant Surge Brings Biotech ETFs in Focus

The biotech sector seems like a lucrative investment space as the delta variant of coronavirus continues to spread.

1 month ago - Zacks Investment Research

Mostly Sanguine Regulatory Outlook for Biotech, Healthcare Names

A change in leadership in the Oval Office often stirs talk about the regulatory environment for the healthcare sector. That talk is often elevated when one party controls the presidency and both houses ...

1 month ago - ETF Trends

Time for Pharma and Healthcare ETFs?

The broader medical sector should gain on decent earnings expectations and higher COVID-19-related sales

Other symbols:FXHIEIHIYHMRNA
2 months ago - Zacks Investment Research

2 Sector ETFs Hovering Around All-Time Highs

The U.S. economic backdrop and investors' sentiments have remained mixed in recent weeks.

2 months ago - Zacks Investment Research

9 Best Biotech ETFs to Play High-Octane Trends

Biotechnology is a dynamic but often volatile industry. These biotech ETFs provide a lower-risk way to invest in the space.

2 months ago - Kiplinger

Changing FDA Regulatory Environment Could Bolster Biotech, ‘BBH'

The Food & Drug Administration's (FDA) recent green light of Biogen's Alzheimer's disease drug Aducanumab – the first new Alzheimer's approval in roughly two decades – could be a sign the FDA is taking ...

2 months ago - ETF Trends

Will Biotech ETFs Benefit from Biogen's New Alzheimer's Drug?

Biotech investors may have reason to celebrate this week, as the FDA approved Biogen's Alzheimer's disease drug Aducanumab on Monday, ushering in the first medication to be allowed by U.S. regulators to...

Other symbols:FBTPBE
3 months ago - ETF Trends

5 Top ETFs With Exposure To Biogen

For the first time in 18 years, there was a new treatment for Alzheimer's Disease approved by the FDA. Aducanumab from Biogen Inc (NASDAQ: BIIB) was approved as a drug that can reduce the clinical decli...

Other symbols:BIIBFBTIBBPBEPKW
3 months ago - Benzinga

Top COVID-19 Vaccine Stories of May Put Biotech ETFs in Focus

Let's take a look at some top coronavirus vaccine stories of May and the possible impact they can have on biotech ETFs.

3 months ago - Zacks Investment Research

Biotech ETFs to Suffer as US Backs IP Waiver for COVID-19 Vaccines

The Biden administration recently informed about supporting the waiver of intellectual property protections for COVID-19 vaccines that has been proposed by South Africa and India.

4 months ago - Zacks Investment Research

How Will Biotech ETFs React to These Q1 Earnings Releases?

Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.

Other symbols:XBIIBB
4 months ago - Zacks Investment Research

Top COVID-19 Vaccine Stories of April Put Biotech ETFs in Focus

Let's take a look at some top coronavirus vaccine stories of April and the possible impact they can have on biotech ETFs.

4 months ago - Zacks Investment Research

Biotech ETFs Make Gains Tuesday, Despite the J&J Vaccine Pause

Some biotech and pharmaceutical ETFs are gaining on Tuesday despite news that Johnson and Johnson's coronavirus vaccine has been halted in over two dozen states, after the Food and Drug Administration r...

Other symbols:FHLCIEIHIHE
5 months ago - ETF Trends

Top COVID-19 Vaccine Stories of March Put Biotech ETFs in Focus

Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence with multiple mutants.

5 months ago - Zacks Investment Research

Biotech Shined with Vaccines. It Can Do It Again with ‘BBH'

The United States and China have been locking horns when it comes to technological advances. ETF investors looking to capitalize on strength in U.S. biotech should give the VanEck Vectors® Biotech ETF (...

6 months ago - ETF Trends

10 ETFs to Buy to Mimic 2021's Best Stock Picks

Investors looking to reduce the risk of owning some of 2021's best stocks might consider these 10 ETFs to buy instead. The post 10 ETFs to Buy to Mimic 2021's Best Stock Picks appeared first on Investor...

7 months ago - InvestorPlace

Illumina Earnings, Forward Guidance Strengthen Biotech ETFs

Biotechnology sector-related exchange traded funds strengthened after Illumina (NasdaqGS: ILMN) announced better-than-expected quarterly earnings and an optimistic 2021 outlook. On Friday, the VanEck Ve...

Other symbols:IBB
7 months ago - ETF Trends

IPOs Are Back. Get In On the Action with the BBH ETF

2020 saw a lot of initial public offerings (IPOs) put on hold thanks to Covid-19. Now that a global vaccine rollout is underway, biotech IPOs are hitting the markets and boosting the VanEck Vectors® Bio...

7 months ago - ETF Trends

How Will Biotech ETFs React to These Q4 Earnings Releases?

Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry post their fourth-quarter earnings releases amid the coronavirus crisis.

Other symbols:IBBXBI
7 months ago - Zacks Investment Research